Genomic Vision (Paris:GV) (FR0011799907 – GV), a biotechnology company developing molecular assays and Artificial Intelligence tools to control quality and safety of genetically modified genomes, today announced that its Molecular Combing technology will be used by the US National Institute of Standards and Technology (NIST) to characterize and quantify intended and unintended genome editing events in […]
Spectris plc (‘Spectris’) (LSE: SXS), the productivity-enhancing instrumentation and controls company, today announces that, together with Macquarie Corporate Holdings Pty Limited (‘Macquarie’), it has agreed to divest the EMS Brüel & Kjær joint venture (‘EMS B&K’) to Envirosuite Limited (‘Envirosuite’). Envirosuite is an environmental management technology company and is listed on the Australian Securities Exchange. […]
( Berlin,16/1/20) From January 27th to 29th the International Sales Meeting will take place at the headquarters of LUM GmbH in Berlin-Adlershof for the 21st time in a row. The sales experts of the LUM companies from Asia, Europe and North America exchange technical information with external sales partners from all over the world. This is where […]
Company continues to advance academic and industry access to precise CRISPR-based synthetic reagents for rapid clinical research and development across disease areas REDWOOD CITY, California – Synthego, the genome engineering company, today announced it has adopted Good Manufacturing Practice (GMP) standards to provide academic and industry partners with high-quality reagents for use in clinical research and development […]
CAMBRIDGE, UK, and LEUVEN, Belgium – EVONETIX LTD (‘Evonetix’), the synthetic biology company developing a desktop platform for scalable, high-fidelity and rapid gene synthesis, today announced it has partnered with imec, a world-leading research and innovation hub active in the fields of nanoelectronics and digital technologies, to increase production of Evonetix’s proprietary microelectromechanical systems (MEMS)-based silicon chips, […]
Certara’s Simcyp® Simulator’s MechDermA™ model provided safety label claim and pediatric dosing information without the need for testing in clinical patients for a topical drug product. Certara®, the global model-informed drug development and decision support leader, today announced that its Simcyp® Population-based Simulator was used to support Galderma’s successful U.S. Food and Drug Administration (FDA) new […]
BC Platforms, a world leader in genomic data management and analytics, today announced that it has formed a partnership with Dante Labs, a global genetic testing and data analysis company specialized in whole genome sequencing and interpretation intended both for Direct To Consumers and larger scale Life Science industry projects. With the steps taken, Dante […]
Quality Immune Checkpoint Proteins Release by Beta Lifescience for the Month of January 2020 FIREFILED, N.J. — Beta Lifescience, a world leading biotech company based in NJ, USA, announces that scientists in the field of cancer immunotherapy, immune checkpoint, targeted therapy, etc. now have access to the quality immune checkpoint protein products through the company’s newly launched website. Immune checkpoints refer to […]
BIO-TECHNE REBRANDS ATLANTA BIOLOGICALS SERUM AND MEDIA AS PART OF THE R&D SYSTEMS PRODUCT PORTFOLIO
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced that the Atlanta Biologicals portfolio of serum and media will be rebranded as R&D Systems. As part of the rebranding, the Atlanta Biologicals website will be retired and the entire serum and media portfolio, including product details and purchasing options, will be maintained through the R&D Systems […]
JEOL Ltd. (headquartered in Akishima, Tokyo; JEOL hereafter) and DI Corporation (headquartered in Gangnam-gu, Seoul, Korea; DI hereafter) entered into an agreement for JEOL to acquire all of DI-owned shares of JEOL KOREA LTD. (headquartered in Gangdong-gu, Seoul, Korea; JK hereafter) and make JK a wholly-owned subsidiary of JEOL. Background and Objective In overseas operations, […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
